Pharma/Medical Device

Pfizer Announces Major Staff Cuts at Irish Plant

Belfast Telegraph
August 08, 2008 - The drugmaker will let 180 workers go from its Cork facility, and concerns have been raised that it may lay off an additional 300 people....
Read Full Text
Add To My Watch List

FDA Approves 2008-2009 Flu Vaccines

U.S. Food and Drug Administration
August 07, 2008 - The agency has licensed products from CSL Limited, GlaxoSmithKline Biologicals, ID Biomedical, MedImmune Vaccines, Novartis Vaccines and Diagnostics, and Sanofi Pasteur....
Read Full Text
Add To My Watch List

FamilyMart to Be First Japanese Retailer to Offer Full Range of OTC Drugs

Jiji Press English News Service (Japan)
August 06, 2008 - The convenience store chain will set up over-the-counter drug sections staffed by pharmacists in two outlets in Tokyo in September....
Read Full Text
Add To My Watch List

ImClone Calls BMS's Purchase Offer Too Low

International Herald Tribune
August 05, 2008 - Rather than merge with Bristol-Myers Squibb, ImClone's board is considering separating its cancer treatment Erbitux and its drug-development businesses....
Read Full Text
Add To My Watch List

I.V. Blood Pressure Treatment Approved by FDA

Business Wire
August 05, 2008 - The Medicines Company's Cleviprex (clevidipine butyrate) can be used when patients are unable to take pills....
Read Full Text
Add To My Watch List

Valeant Minimizes Presence in Europe

Business Wire
August 04, 2008 - The Canadian firm has sold its business operations in Western and Eastern Europe and in certain other export markets to Sweden's Meda AB for $392 million....
Read Full Text
Add To My Watch List

U.S. Seizes Unapproved Medicines at KV Pharmaceutical

St. Louis Post-Dispatch
July 31, 2008 - The company was producing non-FDA-approved versions of a timed-release decongestant....
Read Full Text
Add To My Watch List

Bristol-Myers Squibb Looks to Acquire ImClone

Journal-World
July 31, 2008 - BMS is offer $60 per share in cash for the biotech company whose principal product is the cancer drug Erbitux....
Read Full Text
Add To My Watch List

Bristol-Myers Squibb Looks to Acquire ImClone

Business Wire
July 31, 2008 - BMS is offering $60 per share in cash for the biotech company whose principal product is the cancer drug Erbitux....
Read Full Text
Add To My Watch List

Bayer Sales up 3.6 Pct in Second Quarter

Bayer.com
July 30, 2008 - Board Chairman Werner Wenning said, "We succeeded in significantly improving our operating result although exchange rates remained unfavorable and energy and raw material costs continued to rise."...
Read Full Text
Add To My Watch List
Results 1 - 10 of 33 1 2 3 4



Product Bulletins